Elbow Flexion Cast for Radius Fractures

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Children's of Alabama, Birmingham, AL
Radius Fractures+2 More
Cast - Other
Eligibility
< 65
All Sexes
What conditions do you have?
Select

Study Summary

The purpose of this study is to compare outcomes between two immobilization methods for pediatric proximal half both bone forearm fractures.

Eligible Conditions

  • Radius Fractures
  • Fracture of Radius and Ulna

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: This will be accessed in clinic via x-rays at 2, 3, 5, and 8 weeks following the application of the cast.

Week 8
Cast Complications
Week 8
Alignment/Loss of Reduction

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Elbow Flexion Cast
1 of 2
Elbow Extension Cast
1 of 2
Experimental Treatment

75 Total Participants · 2 Treatment Groups

Primary Treatment: Elbow Flexion Cast · No Placebo Group · N/A

Elbow Flexion Cast
Other
Experimental Group · 1 Intervention: Cast · Intervention Types: Other
Elbow Extension Cast
Other
Experimental Group · 1 Intervention: Cast · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: this will be accessed in clinic via x-rays at 2, 3, 5, and 8 weeks following the application of the cast.

Trial Background

Prof. Philip Ashley, Assistant Professor
Principal Investigator
University of Alabama at Birmingham
Closest Location: Children's of Alabama · Birmingham, AL
Photo of Birmingham  1Photo of Birmingham  2Photo of Birmingham  3
2013First Recorded Clinical Trial
1 TrialsResearching Radius Fractures
14 CompletedClinical Trials

Eligibility Criteria

Age < 65 · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are skeletally immature.
You have a fracture of the radius or ulna located within the proximal ½ of each bone.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.